Galectin Therapeutics Shares Outstanding 2006-2018 | GALT

Galectin Therapeutics shares outstanding history from 2006 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Galectin Therapeutics shares outstanding for the quarter ending June 30, 2018 were 0.038B, a 10.19% increase year-over-year.
  • Galectin Therapeutics 2017 shares outstanding were 0.036B, a 21.58% increase from 2016.
  • Galectin Therapeutics 2016 shares outstanding were 0.029B, a 21.13% increase from 2015.
  • Galectin Therapeutics 2015 shares outstanding were 0.024B, a 10.39% increase from 2014.
Galectin Therapeutics Annual Shares Outstanding
(Millions of Shares)
2017 36
2016 29
2015 24
2014 22
2013 17
2012 15
2011 12
2010 9
2009 8
2008 8
2007 7
2006 5
2005 5
Galectin Therapeutics Quarterly Shares Outstanding
(Millions of Shares)
Q2 2018 38
Q1 2018 37
Q4 2017 36
Q3 2017 35
Q2 2017 35
Q1 2017 34
Q4 2016 29
Q3 2016 29
Q2 2016 29
Q1 2016 29
Q4 2015 24
Q3 2015 24
Q2 2015 24
Q1 2015 23
Q4 2014 22
Q3 2014 22
Q2 2014 22
Q1 2014 20
Q4 2013 17
Q3 2013 17
Q2 2013 16
Q1 2013 16
Q4 2012 16
Q3 2012 16
Q2 2012 16
Q1 2012 13
Q4 2011 13
Q3 2011 12
Q2 2011 12
Q1 2011 11
Q4 2010 10
Q3 2010 10
Q2 2010 9
Q1 2010 8
Q4 2009 8
Q3 2009 8
Q2 2009 8
Q1 2009 8
Q4 2008 8
Q3 2008 7
Q2 2008 9
Q1 2008 7
Q4 2007 11
Q3 2007 7
Q2 2007 7
Q1 2007 6
Q4 2006 4
Q3 2006 4
Q2 2006 3
Q1 2006 5
Q4 2005 4
Q3 2005 5
Q2 2005 5
Q1 2005 5
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.246B $0.000B
Galectin Therapeutics Inc. is a drug development company engaged in the development new therapies for fibrotic disease and cancer. The Company uses its carbohydrate technology that targets galectin proteins, the key mediators of biologic and pathologic function. Galectin Therapeutics uses naturally occurring carbohydrate polymers with galactose residues to create complex carbohydrates with specific molecular weights. Galectin Therapeutics, formerly known as Pro-Pharmaceuticals, Inc. is headquartered in Newton, Massachusetts.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $54.150B 11.47
Zoetis (ZTS) United States $42.969B 31.18
Tilray (TLRY) United States $14.435B 0.00
Grifols (GRFS) Spain $14.360B 18.61
Neurocrine Biosciences (NBIX) United States $10.880B 0.00
Nektar Therapeutics (NKTR) United States $10.060B 11.76
Jazz Pharmaceuticals (JAZZ) Ireland $9.782B 14.39
Impax Laboratories (AMRX) United States $7.002B 37.24
Sage Therapeutics (SAGE) United States $6.858B 0.00
Ionis Pharmaceuticals (IONS) United States $6.776B 0.00
Catalent (CTLT) United States $6.212B 26.80
United Therapeutics (UTHR) United States $5.498B 7.06
FibroGen (FGEN) United States $4.837B 0.00
Loxo Oncology (LOXO) United States $4.802B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.893B 15.07
Endo (ENDP) Ireland $3.569B 5.13
Madrigal Pharmaceuticals (MDGL) United States $3.186B 0.00
USANA Health Sciences (USNA) United States $3.010B 26.52
Heron Therapeutics (HRTX) United States $2.659B 0.00
Ironwood Pharmaceuticals (IRWD) United States $2.648B 0.00
Aerie Pharmaceuticals (AERI) United States $2.557B 0.00
Xencor (XNCR) United States $2.536B 0.00
PTC Therapeutics (PTCT) United States $2.372B 0.00
Spectrum Pharmaceuticals (SPPI) United States $2.163B 0.00
TESARO (TSRO) United States $1.964B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.960B 0.00
Portola Pharmaceuticals (PTLA) United States $1.868B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.762B 21.55
Zogenix (ZGNX) United States $1.743B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.658B 0.00
Corcept Therapeutics (CORT) United States $1.655B 25.46
Tricida (TCDA) United States $1.496B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.488B 0.00
TherapeuticsMD (TXMD) United States $1.417B 0.00
ImmunoGen (IMGN) United States $1.347B 0.00
Esperion Therapeutics (ESPR) United States $1.267B 0.00
Endocyte (ECYT) United States $1.264B 0.00
Karyopharm Therapeutics (KPTI) United States $1.125B 0.00
Radius Health (RDUS) United States $0.796B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.782B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.760B 0.00
Flexion Therapeutics (FLXN) United States $0.749B 0.00
Dova Pharmaceuticals (DOVA) United States $0.698B 0.00
GlycoMimetics (GLYC) United States $0.628B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.586B 0.00
ChemoCentryx (CCXI) United States $0.566B 33.88
OptiNose (OPTN) United States $0.563B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.549B 0.00
ArQule (ARQL) United States $0.546B 0.00
Siga Technologies (SIGA) United States $0.531B 0.00
Odonate Therapeutics (ODT) United States $0.519B 0.00
CASI Pharmaceuticals (CASI) United States $0.497B 0.00
Xeris Pharmaceuticals (XERS) United States $0.495B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.485B 0.00
Collegium Pharmaceutical (COLL) United States $0.472B 0.00
Translate Bio (TBIO) United States $0.467B 0.00
Aclaris Therapeutics (ACRS) United States $0.464B 0.00
Dermira (DERM) United States $0.456B 0.00
Akebia Therapeutics (AKBA) United States $0.444B 0.00
Minerva Neurosciences (NERV) United States $0.430B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.425B 28.97
Verrica Pharmaceuticals (VRCA) United States $0.423B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.419B 0.00
Forty Seven (FTSV) United States $0.418B 0.00
ElectroCore (ECOR) United States $0.410B 0.00
Aquestive Therapeutics (AQST) United States $0.401B 0.00
Mast Therapeutics (SVRA) United States $0.394B 0.00
Zafgen (ZFGN) United States $0.382B 0.00
Depomed (ASRT) United States $0.376B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.340B 0.00
MEI Pharma (MEIP) United States $0.323B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.318B 0.00
Concert Pharmaceuticals (CNCE) United States $0.314B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.306B 0.00
Opexa Therapeutics (ACER) United States $0.298B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.292B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.272B 0.00
Affimed (AFMD) Germany $0.271B 0.00
Aratana Therapeutics (PETX) United States $0.260B 0.00
IMV INC (IMV) Canada $0.251B 0.00
Melinta Therapeutics (MLNT) United States $0.249B 0.00
Neon Therapeutics (NTGN) United States $0.247B 0.00
Ocular Therapeutix (OCUL) United States $0.242B 0.00
Ardelyx (ARDX) United States $0.242B 0.00
Tyme Technologies (TYME) United States $0.228B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.227B 0.00
Jounce Therapeutics (JNCE) United States $0.220B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.212B 0.00
KalVista Pharmaceuticals (KALV) United States $0.202B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.201B 0.00
Achaogen (AKAO) United States $0.194B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.189B 0.00
Lannett Co Inc (LCI) United States $0.185B 1.53
DURECT (DRRX) United States $0.183B 0.00
MediWound (MDWD) Israel $0.175B 0.00
Nature's Sunshine Products (NATR) United States $0.172B 0.00
Calithera Biosciences (CALA) United States $0.171B 0.00
Redhill Biopharma (RDHL) Israel $0.170B 0.00
Aldeyra Therapeutics (ALDX) United States $0.165B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.158B 0.00
Adherex Technologies (FENC) United States $0.157B 0.00
Cardiome Pharma (CORV) Canada $0.155B 0.00
Immune Design (IMDZ) United States $0.154B 0.00
Recro Pharma (REPH) United States $0.154B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.153B 0.00
Neos Therapeutics (NEOS) United States $0.147B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.142B 0.00
Champions Oncology (CSBR) United States $0.137B 0.00
ProNAi Therapeutics (SRRA) Canada $0.136B 0.00
ContraFect (CFRX) United States $0.133B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.128B 0.00
Forward Pharma (FWP) Denmark $0.122B 0.00
Infinity Pharmaceuticals (INFI) United States $0.121B 0.00
Iterum Therapeutics (ITRM) Ireland $0.120B 0.00
Rafael Holdings (RFL) United States $0.115B 0.00
Molecular Templates (MTEM) United States $0.111B 0.00
CTI BioPharma (CTIC) United States $0.109B 0.00
BioLineRx (BLRX) Israel $0.096B 0.00
Trillium Therapeutics (TRIL) Canada $0.091B 0.00
Nivalis Therapeutics (ALPN) United States $0.090B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.087B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.080B 0.00
KemPharm (KMPH) United States $0.080B 0.00
Otonomy (OTIC) United States $0.080B 0.00
Novan (NOVN) United States $0.074B 0.00
Natural Alternatives (NAII) United States $0.073B 9.32
Opiant Pharmaceuticals (OPNT) United States $0.060B 50.40
SCYNEXIS (SCYX) United States $0.059B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.055B 0.00
Mannatechorporated (MTEX) United States $0.048B 25.44
Tokai Pharmaceuticals (NVUS) United States $0.046B 0.00
India Globalization Capital (IGC) United States $0.044B 0.00
Heat Biologics (HTBX) United States $0.044B 0.00
Capnia (SLNO) United States $0.043B 0.00
Genocea Biosciences (GNCA) United States $0.043B 0.00
Onconova Therapeutics (ONTX) United States $0.043B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.040B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.038B 0.00
Avenue Therapeutics (ATXI) United States $0.037B 0.00
ProPhase Labs (PRPH) United States $0.035B 3.90
Lipocine (LPCN) United States $0.033B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.032B 0.00
IsoRay (ISR) United States $0.032B 0.00
Biomerica (BMRA) United States $0.030B 0.00
NanoViricides (NNVC) United States $0.028B 0.00
Jaguar Animal Health (JAGX) United States $0.028B 0.00
Can-Fite Biopharma (CANF) Israel $0.026B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.026B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.025B 0.00
HANCOCK JAFFE (HJLI) United States $0.025B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.023B 0.00
Xenetic Biosciences (XBIO) United States $0.023B 0.00
Midatech Pharma (MTP) United Kingdom $0.022B 0.00
Citius Pharmaceuticals (CTXR) United States $0.022B 0.00
Cyanotech (CYAN) United States $0.021B 0.00
Shineco (TYHT) China $0.021B 1.82
Regulus Therapeutics (RGLS) United States $0.020B 0.00
Egalet (EGLT) United States $0.019B 0.00
Aradigm (ARDM) United States $0.018B 0.00
Aviragen Therapeutics (VXRT) United States $0.018B 0.00
ESSA Pharma (EPIX) Canada $0.018B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.018B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.015B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.015B 0.00
Skyline Medical (AIPT) United States $0.014B 0.00
Bio-Path Holdings (BPTH) United States $0.012B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.012B 0.00
Intellipharmaceutics (IPCI) Canada $0.011B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.011B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.008B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.007B 0.00
Pain Therapeutics (PTIE) United States $0.007B 0.00
Apricus Biosciences (APRI) United States $0.007B 0.00
PharmAthene (ALT) United States $0.005B 0.00
RXi Pharmaceuticals (RXII) United States $0.005B 0.00
Biostar Pharmaceuticals (BSPM) China $0.005B 2.69
Bio Blast Pharma (ORPN) Israel $0.004B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00